300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 35 Life Science Angel Investors in Germany (September 2026)

The most active angel investors investing in Germany Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Germany Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
Holger Hübner
Angel
2 Germany Seed, Pre-Seed B2B, SaaS, Audio $177k–$1.1M
Michael Novogratz
Angel
2 United States, India, Germany Seed, Series A, Series B Blockchain, Cryptocurrency, FinTech $1.1M–$150M
Albert Wenger
Angel
2 United States, Germany, Switzerland Series A, Series B, Seed Software, Internet, Analytics $650k–$30M
Carsten Maschmeyer
Angel
2 Germany, Austria, Switzerland Seed, Angel, Series A Software, Artificial Intelligence, Information Technology $89k–$24M
Thor Bjorgolfsson
Angel
2 United Kingdom, Germany Seed, Series A, Series C Big Data, TV, B2B $26M–$26M
Nico Wittenborn
Angel
2 United States, Germany, France Seed, Series A, Series B Software, Apps, Wellness $1.6M–$88M
Dr Guntard Gutmann
Angel
2 Germany Convertible Note, Venture - Series Unknown Health Care, Life Science, Therapeutics
Balaji Srinivasan
Angel
2 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $650k–$28M
Ersin Pamuksüzer
Angel
2 Turkey, Germany Seed, Series A Education, Life Science, Virtual Reality $300k–$500k
Nitin Sharma
Angel
1 India, United States, Germany Pre-Seed, Seed, Grant Financial Services, Software, Information Technology $165k–$11M
Katelyn Donnelly
Angel
1 United States, Germany Seed, Pre-Seed, Series A Artificial Intelligence, Software, Education $600k–$13M
Brian Fabian Crain
Angel
1 Germany, Switzerland, United States Seed Web3, Bitcoin, Software $2.3M–$13M
Günther Strunk
Angel
1 Germany Pre-Seed Video Games, Life Science, Therapeutics
Todd White
Angel
1 Germany Seed Software, Blockchain, Health Care
İzzet Halyo
Angel
1 Turkey, Germany, United Kingdom Seed, Angel Education, Artificial Intelligence, Dental $140k–$1.2M
Emre Yılmaz
Angel
1 Germany Pre-Seed Education, Life Science, Bioinformatics
Till Knorr
Angel
1 Germany Seed Health Care, Life Science, Biotechnology
Nikolaus Sturm
Angel
1 Germany Seed Life Science, Biotechnology
Bhavik Bajaj
Angel
1 United States, Switzerland, United Kingdom Pre-Seed, Seed, Angel Software, Information Technology, SaaS $15k–$5M
Susanna Zapreva
Angel
1 Germany Seed Health Care, Life Science, Biotechnology
Michel Lurquin
Angel
1 Germany Seed News, Life Science, Social Media
Wilhelm Beier
Angel
1 Germany Venture - Series Unknown Health Care, Life Science, Therapeutics
Steve Wiggins
Angel
1 United States, Germany Seed, Private Equity, Series C Health Care, Medical, Payments $13M–$34M
Zen Chu
Angel
1 United States, Canada, Germany Series A, Seed Health Care, Medical, Life Science $1.1M–$60M
Hans Kompernaß
Angel
1 Germany Venture - Series Unknown Health Care, Life Science, Therapeutics
Tim Schlidt
Angel
1 Germany, United Kingdom Seed Software, Blockchain, Health Care $4.5M–$13M
Qiao Wang
Angel
1 United States, Singapore, China Seed, Pre-Seed, Venture - Series Unknown Blockchain, Software, Cryptocurrency $350k–$12M
Tim Peterson
Angel
1 Germany Seed Software, Blockchain, Health Care
Simon Bungers
Angel
1 Germany Seed News, Life Science, Social Media
Ronjon Nag
Angel
1 United Kingdom, United States, Canada Seed, Pre-Seed, Series B Artificial Intelligence, Software, Health Care $472k–$13M
Sven Fund
Angel
1 Germany, Italy, Ireland Seed, Pre-Seed, Venture - Series Unknown Publishing, Events, Digital Media $250k–$3M
Barbara Korte-Sturm
Angel
1 Germany Seed Life Science, Biotechnology
Bertrand Landel
Angel
1 Germany Seed News, Life Science, Social Media
Ülkü Özeren
Angel
1 Germany Series A Education, Life Science, Virtual Reality
Access all 55 angel investors in Germany Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Andrew Keys
Angel · 3 investments in Germany Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany · 2 investments in Germany Life Science startups

Holger Hübner

Show more...

Investment focus

  • Industry: B2B, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $560k–$1.1M; Pre-Seed $177k–$342k
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Michael Novogratz
Angel · New York, New York, United States · 2 investments in Germany Life Science startups

Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 34
  • Round size: Seed $1.1M–$8M; Series A $11M–$38M; Series B $15M–$150M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
Show all investments...

Albert Wenger
Angel · New York, New York, United States · 2 investments in Germany Life Science startups

Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Show more...

Investment focus

  • Industry: Software, Internet, Analytics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 110
  • Round size: Seed $650k–$16M; Series A $1M–$23M; Series B $4.3M–$30M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Phlair — 77NEKO menjadi salah satu akses asli untuk bermain game online yang menghasilkan sulthan dengan secara sekejap. Bukan hanya itu tapi 77neko sering memberikan bonus yang gokil seperti petir merah yang tak terhingga, cashback 100% hingga spin gratis di setiap permainan.
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany · 2 investments in Germany Life Science startups

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Angel, Series A
  • Geography: Germany, Austria, Switzerland

Investor stats

  • Total investments: 83
  • Round size: Seed $116k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
  • admark.ai — admark.ai combines cutting-edge AI language models with social media data
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom · 2 investments in Germany Life Science startups

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Industry: Big Data, TV, B2B
  • Stage:Seed, Series A, Series C
  • Geography: United Kingdom, Germany

Investor stats

  • Total investments: 6
  • Round size: Series A $26M–$26M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States · 2 investments in Germany Life Science startups

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Industry: Software, Apps, Wellness
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, France

Investor stats

  • Total investments: 47
  • Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Mirage — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Show all investments...

Dr Guntard Gutmann
Angel · 2 investments in Germany Life Science startups

Dr Guntard Gutmann

Show more...

Investment focus

  • Industry: Health Care, Life Science, Therapeutics
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: Germany

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 2 investments in Germany Life Science startups, 17 in the past 12 months

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 275
  • Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
  • Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
  • Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
Show all investments...

Ersin Pamuksüzer
Angel · Bodrum, Mugla, Turkey · 2 investments in Germany Life Science startups

Ersin Pamuksüzer

Show more...

Investment focus

  • Industry: Education, Life Science, Virtual Reality
  • Stage:Seed, Series A
  • Geography: Turkey, Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $300k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aposto — All-in-one media service currently based in Istanbul, Turkey.
  • VRLab Academy — VRLab Academy | Virtual Experiments
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nitin Sharma
Angel · Bangalore, Karnataka, India · 1 investments in Germany Life Science startups

For the last 10+ years, I've had the rare fortune of working with world-class entrepreneurs - as a venture or angel investor, startup team member or growth advisor - in the US and in India. Experience: US VC - Investor @ NEA India VC - Principal & Founding Member @ Lightbox (ex. Kleiner Perkins India and Sherpalo) Startup ops in the US- VP, Bus Dev and early employee @ EverFi (one of the largest edtech networks globally) Startup ops in India - Key leadership responsibilities related to 4 Lightbox companiesCurrently, I am especially spending a large portion of my time on blockchain startups and cryptocurrencies. INVESTING: Lots of learnings from working on early to growth stage investments. US: Millennial Media (IPO, acq. by AOL), OPOWER (IPO, acq. by Oracle), Gilt Groupe (acq. by Saks / Hudson Bay), ChannelAdvisor (IPO), AddThis (acq. by Oracle), EverFi, Suniva, Videology, Credibase, new crypto and blockchain projects India: Droom, Melorra, Paymate, Zoomin, Stalkbuylove, Fynd, The Better India, Mech MochaSTARTUP OPERATIONS: Hands-on experience in both hyper-growth and turnaround situations. Wore a few hats as an early employee and head of BD at EverFi (one of the largest edtech networks globally having served 16MM students and raised $250MM), led strategic finance projects for NEA companies Suniva and AddThis, and interned at InMobi. Owned or helped solve problems across strategy, M&A, senior hiring, int'l expansion and fundraising while working closely with management at Droom, Melorra, Paymate and Zoomin

Show more...

Investment focus

  • Industry: Financial Services, Software, Information Technology
  • Stage:Pre-Seed, Seed, Grant
  • Geography: India, United States, Germany

Investor stats

  • Total investments: 46
  • Round size: Seed $572k–$11M; Pre-Seed $165k–$2M
  • Lead/follow: 72% lead, 28% follow

Portfolio highlights

  • Klub — India's leading Revenue Based Financing platform with a vision to revolutionize growth capital. Join the Klub for fast, fair & flexible funding.
  • StayQrious — StayQrious is an ed-tech startup that focuses on skilling students in computer applications such as coding through online group classes. The company also focuses on collaboration, critical thinking, and creativity through these virtual classrooms.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Katelyn Donnelly
Angel · New York, New York, United States · 1 investments in Germany Life Science startups

Katelyn Donnelly is the General Partner at Avalanche VC. She attended Duke University.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Education
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Germany

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$13M; Pre-Seed $600k–$1.4M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Bluesky — Bluesky is a new social media platform.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
  • Civic Marketplace — Civic Marketplace is a platform that simplifies purchasing decisions, helps agencies make efficient, informed choices, and boosts local economic growth by providing access and opportunities to historically underutilized businesses.
Show all investments...

Brian Fabian Crain
Angel · Berlin, Berlin, Germany · 1 investments in Germany Life Science startups

Brian Fabian Crain is a Berlin-based economist and entrepreneur. He is the founder and co-host of the blockchain podcast Epicenter (250+ episodes, 4m+ downloads), founder and ​organizer of Blockchain Meetup Berlin. He is also co-founder & CEO of Chorus One.​He has degrees in economics, philosophy and cognitive science from the University ofChicago, London ​School of Economics​ and University ​College ​London.​

Show more...

Investment focus

  • Industry: Web3, Bitcoin, Software
  • Stage:Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 3
  • Round size: Seed $2.3M–$13M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bima Labs — Bima Labs provides Bitcoin-backed stable coins.
  • Turtle Club — Aggregated, diligenced, personalized onchain yield management.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Günther Strunk
Angel · 1 investments in Germany Life Science startups

Günther Strunk

Show more...

Investment focus

  • Industry: Video Games, Life Science, Therapeutics
  • Stage:Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Show all investments...

Todd White
Angel · 1 investments in Germany Life Science startups

Todd White is an angel investor.

Show more...

Investment focus

  • Industry: Software, Blockchain, Health Care
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

İzzet Halyo
Angel · 1 investments in Germany Life Science startups

İzzet Halyo

Show more...

Investment focus

  • Industry: Education, Artificial Intelligence, Dental
  • Stage:Seed, Angel
  • Geography: Turkey, Germany, United Kingdom

Investor stats

  • Total investments: 12
  • Round size: Seed $300k–$1.2M; Angel $140k–$346k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • İyi Yaşa — İyi Yaşa offers highest quality trainings and videos, inspire and activate both sports and health enthusiasts and those who want to step into a good life with suitable alternatives for all levels. It offers fitness, yoga, mindfulness classes and healthy recipes, nutrition informations and workshops.
  • dentalPrices — Your dental health is important to you. Don't postpone your appointment anymore, make an online appointment now.!
  • Komunite — Komünite is Turkey's methodology-driven digital entrepreneurship platform, founded in 2021 to transform how independent creators and micro-entrepreneurs build sustainable businesses. Rather than relying on innate talent or chance, Komünite champions a systematic approach to venture building—what it calls "Metot Girişimcilik"(Methodical Entrepreneurship)—where learnable frameworks replace guesswork and data-driven iteration replaces intuition.The platform operates across three integrated verticals:• Komünite (Core Platform): An online community of digital entrepreneurs, content creators, designers, and freelancers supported by 36 specialized forum channels, structured mentorship programs, and regular events including Tool Night, AMA sessions, Speed Networking, and Founder's Talk. Members gain access to educational resources, collaborative project opportunities, and the Katma Değer Fonu—an in-house investment fund providing $2,000–$7,000 in seed capital to promising digital ventures in exchange for 30% equity stakes.• Komünite Space: A 160m² physical innovation hub located in Vadistanbul, Istanbul, featuring event capacity for 80 seated or 160 standing attendees, a professional video production studio, and flexible workspace configurations. The venue hosts workshops, corporate training programs, and sector-specific networking events that bridge online community engagement with real-world collaboration.• Lokomotif AI: The corporate training arm delivering generative AI programs to enterprises. Offerings include AI Leadership seminars for executives, AI Literacy workshops for teams, AI Strategy development programs, and monthly AI Trends briefings. Lokomotif AI also provides automation consulting and custom AI-powered digital product development services.Komünite addresses a structural gap in Turkey's entrepreneurship ecosystem: the isolation, resource scarcity, and methodological uncertainty that constrain independent digital creators. Through its rolling fund model, physical infrastructure, and enterprise training revenue streams, the platform has built a self-reinforcing ecosystem where corporate clients fund community growth, successful ventures generate reinvestable returns, and members progress from learners to mentors to founders.The platform's venture studio arm, Komünite Stüdyo, develops digital products for external clients while serving as a proving ground for member talent, matching projects with specialists from its internal database based on demonstrated competencies and track records.
Show all investments...

Emre Yılmaz
Angel · 1 investments in Germany Life Science startups

Angel Investor, Full Stack Web Developer

Show more...

Investment focus

  • Industry: Education, Life Science, Bioinformatics
  • Stage:Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Bioinformy — Join us and explore the dynamic world of molecular biology and big data analysis through engaging lessons, interactive exercises, and expert-led discussions.
Show all investments...

Till Knorr
Angel · 1 investments in Germany Life Science startups

Till Knorr

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Belyntic — Difficulties in peptide manufacturing? Our advanced peptide technology platform enables you to generate even the most difficult sequences with seemless choice in throughput and scale. We offer the worlds's first broadly applicable purification kits without the need for costly instrumentation. Check out the ultimate tool for your peptideworkflows and possibilities to develop most efficient peptide drugs.
Show all investments...

Nikolaus Sturm
Angel · 1 investments in Germany Life Science startups

Nikolaus Sturm

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Show all investments...

Bhavik Bajaj
Angel · 1 investments in Germany Life Science startups

Bhavik Bajaj

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 78
  • Round size: Seed $100k–$5M; Angel $15k–$1.6M; Pre-Seed $46k–$1.4M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
  • ORA Technologies — E-Commerce, Super App
  • THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Susanna Zapreva
Angel · 1 investments in Germany Life Science startups

Susanna Zapreva is the ceo of enercity .

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Phaeosynt — Phaeosynt is a biotechnology company that produces animal-free antibodies using microalgae and diatomaceous earth.
Show all investments...

Michel Lurquin
Angel · 1 investments in Germany Life Science startups

Michel Lurquin

Show more...

Investment focus

  • Industry: News, Life Science, Social Media
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Show all investments...

Wilhelm Beier
Angel · 1 investments in Germany Life Science startups

Wilhelm Beier is the chairman of the supervisory board of Dermapharm.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Therapeutics
  • Stage:Venture - Series Unknown
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Show all investments...

Steve Wiggins
Angel · New York, New York, United States · 1 investments in Germany Life Science startups

Steve Wiggins is the Founder and Chairman of Wiggins Ventures. He attended Southeast Missouri State University.

Show more...

Investment focus

  • Industry: Health Care, Medical, Payments
  • Stage:Seed, Private Equity, Series C
  • Geography: United States, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $13M–$34M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Aligned — Aligned is building a suite of products and services aimed to empower the growing decentralized financial movement spanning high performance computing, mining, staking and liquidity provisioning while supporting decentralization with immutable, full-stack infrastructure for DeFi.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
  • UST HealthProof — UST HealthProof is a healthcare technology company that provides an integrated ecosystem of platform-based solutions for health plan operations.
Show all investments...

Zen Chu
Angel · Cambridge, Massachusetts, United States · 1 investments in Germany Life Science startups

Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST)program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU.  He's married to another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.

Show more...

Investment focus

  • Industry: Health Care, Medical, Life Science
  • Stage:Series A, Seed
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$13M; Series A $1.1M–$60M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lora DiCarlo — Lora DiCarlo used biomimicry to translate human mouth, tongue, and finger-like haptics into microrobotic mechanisms that feel like a human partner. Osé adjusts to each woman's unique physiology for a personal fit that makes achieving the elusive blended orgasm easy.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
  • MycoMedica Life Sciences, PBC — Psychedelic Medicines
Show all investments...

Hans Kompernaß
Angel · Cologne, Nordrhein-Westfalen, Germany · 1 investments in Germany Life Science startups

Hans Kompernaß of Hans Kompernaß GmbH.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Therapeutics
  • Stage:Venture - Series Unknown
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Show all investments...

Tim Schlidt
Angel · 1 investments in Germany Life Science startups

Investment focus

  • Industry: Software, Blockchain, Health Care
  • Stage:Seed
  • Geography: Germany, United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $4.5M–$13M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • wavepaths — Wavepaths creates accessible tools, that deepen their connection with ourselves and others, and expand their potential to have life changing experiences.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Qiao Wang
Angel · Manhattan, New York, United States · 1 investments in Germany Life Science startups

Qiao Wang is a believer in decentralized technologies such as cryptocurrencies that shift the balance of power from the elite to the commoner.

Show more...

Investment focus

  • Industry: Blockchain, Software, Cryptocurrency
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Singapore, China

Investor stats

  • Total investments: 32
  • Round size: Seed $1.1M–$12M; Pre-Seed $350k–$3M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • AltLayer — AltLayer is a system of highly scalable application-dedicated execution layers that derive security from an underlying L1/L2.
  • NEBRA Labs — NEBRA Labs is a blockchain services company.
  • Slide — Slide.so is a premium domain name listed for sale. Secure escrow transfer and lease-to-own options available.
Show all investments...

Tim Peterson
Angel · Cambridge, Massachusetts, United States · 1 investments in Germany Life Science startups

Founder @Onarbor. Systems biologist @Harvard.

Show more...

Investment focus

  • Industry: Software, Blockchain, Health Care
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Simon Bungers
Angel · 1 investments in Germany Life Science startups

Simon Bungers

Show more...

Investment focus

  • Industry: News, Life Science, Social Media
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ronjon Nag
Angel · San Francisco, California, United States · 1 investments in Germany Life Science startups

Dr. Ronjon Nag is CEO/Co-Founder of Cellmania & R42 Group, a leading wireless applications company. Dr. Nag, is an acknowledged authority in the mobile industry, having been featured on the cover of Fortune and involved in the development of, and holding patents in, wireless applications, user interfaces and new m-commerce distributionmethods of mobile applications and devices. Previously a Vice President and General Manager at Motorola responsible for smart mobile technologies developed in the Lexicus Division and Motorola Human Interface Laboratories worldwide, hundreds of millions of Motorola devices have shipped with technology developed under his leadership - voice recognition, handwriting recognition and predictive text key systems. Previously Dr. Nag was CEO/founder of Lexicus, a pioneer of speech and handwriting recognition technology, acquired by Motorola in 1993. Dr. Nag holds a Ph.D. from Cambridge University (speech recognition research), was a Harkness Fellow at Stanford University (neural network research), has an MBA from MIT, and a 1st class Honours degree of Birmingham University, UK (electrical engineering).

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 14
  • Round size: Seed $1.2M–$13M; Pre-Seed $472k–$2M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Introhive — Introhive is a Relationship Intelligence platform that helps firms overcome data silos and unlock actionable relationship insights that drive collaboration and growth.
  • Civil Maps — The Civil Maps sensor-agnostic platform enables high-accuracy, low-cost 3D HD mapping and localization at scale. Auto OEMs, mapping companies, and mobility providers use our technology to advance their autonomous driving initiatives by integrating our localization technology with their decision-making stack and sensor configurations of choice.Civil Maps enables vehicles to develop and leverage their own “mental model” of the world; they can can create, utilize, and create maps with the industry’s most cost-effective, scalable, and robust methods available today. Civil Maps’ proprietary Fingerprint Basemap Technology is at the core of our offerings in sensor fusion, 3D mapping, centimeter-accurate localization at scale. While empowering vehicles with full environmental awareness and enhanced safety, Civil Maps is able to dramatically reduce the cost, compute, and energy requirements involved in continental-scale deployment of delivery bots and autonomous vehicles.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Sven Fund
Angel · Berlin, Berlin, Germany · 1 investments in Germany Life Science startups

Sven Fund - Managing Director @ Fullstopp

Show more...

Investment focus

  • Industry: Publishing, Events, Digital Media
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Germany, Italy, Ireland

Investor stats

  • Total investments: 9
  • Round size: Seed $250k–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • UNFIA — The marketplace of craft wine
  • Ex Ordo — Ex Ordo is a Galway-based software company whose web applications enable research conference organisers to manage successful and career-enhancing events at which researchers can publish papers and collaborate together. Their web applications automate the mundane, time-consuming tasks, saving organisers an average of 15 days, €5 to €15k, overthe life of a conference.
  • SciFlow — SciFlow is a comprehensive publishing platform that allows researchers to focus on what is important – their research. We offer an intuitive text editor that helps to focus on writing – not formatting – the document. All co-authors can write, comment and review the same version of the article. With our premium services, we allow researchers tocheck for plagiarism and spelling errors and to translate their text. With one click, the article is exported to a publisher compliant format. Unlike existing text editors, researchers can perform all tasks related to publishing scientific texts with SciFlow on a single platform. Thus, SciFlow saves time and gives the confidence to submit an article to a publisher.
Show all investments...

Barbara Korte-Sturm
Angel · 1 investments in Germany Life Science startups

Barbara Korte-Sturm

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Show all investments...

Bertrand Landel
Angel · Basel, Basel-Stadt, Switzerland · 1 investments in Germany Life Science startups

Bertrand Landel - International Business Operations & Development @ Ender Diagnostics

Show more...

Investment focus

  • Industry: News, Life Science, Social Media
  • Stage:Seed
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Show all investments...

Ülkü Özeren
Angel · 1 investments in Germany Life Science startups

Ulku (Kocaman) Ozeren is a Managing Partner at SIM Sustainability, Innovation and Management Consultancy Inc.

Show more...

Investment focus

  • Industry: Education, Life Science, Virtual Reality
  • Stage:Series A
  • Geography: Germany

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VRLab Academy — VRLab Academy | Virtual Experiments
Show all investments...

Life Science Angel investor funding in Germany at a glance

Stats across 29 deals from 55 investors.

55
investors
in Germany Life Science startups
29
deals
in Germany Life Science startups
$7.5M
median round
in Germany Life Science startups
9%
lead investors
lead at least one round
34%
Seed
most common funding stage

Access all 55 angel investors in Germany Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 55 angel investors investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists